Spire Healthcare Group PLC header image

Spire Healthcare Group PLC

SPI

Equity

ISIN GB00BNLPYF73 / Valor 24881418

LSE London Stock Exchange, SETS (2026-05-01)
GBP 1.64+0.86%

Spire Healthcare Group PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Spire Healthcare Group PLC, established in 2007 through the acquisition and rebranding of 25 Bupa hospitals, is a prominent independent healthcare provider in the United Kingdom. Listed on the London Stock Exchange and part of the FTSE 250, the company operates 38 hospitals and over 50 clinics, medical centres, and consulting rooms across England, Wales, and Scotland. Spire Healthcare offers a comprehensive range of services, including diagnostics, inpatient, day case, and outpatient care, with specialties in orthopaedics, gynaecology, cardiology, neurology, oncology, and general surgery. Additionally, the group provides private GP services, mental health, dermatological, and musculoskeletal care, and occupational health services to over 800 corporate clients. Notably, Spire is the leading independent provider of knee and hip operations by volume in the UK, underscoring its significant role in the healthcare sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-14.9%1Y
-28.1%3Y
-17.8%5Y

Performance

47.3%1Y
33.3%3Y
32.5%5Y

Volatility

Market cap

894 M

Market cap (USD)

Daily traded volume (Shares)

400,367

Daily traded volume (Shares)

1 day high/low

2.25 / 2.23

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 21.88
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.60%USD 12.39
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%USD 2.84
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 4.36
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.59%USD 68.56
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc Protagonist Therapeutics Inc Valor: 33278818
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%USD 98.37
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 2.15
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-24.91%USD 16.11
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.40%USD 140.22
Quanterix Corporation
Quanterix Corporation Quanterix Corporation Valor: 39127916
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.63%USD 3.40